$ELSE
ELECTRO SENSORS INC Stock $else

$else Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000089710124000170 Filed on May 10, 2024

Income Statement

Concept	2024 Q2	2024 Q1
Revenue	$2.217M	$2.244M
YoY Change	3.74%	9.73%
Cost Of Revenue	$1.170M	$1.164M
YoY Change	9.45%	13.78%
Gross Profit	$1.047M	$1.080M
YoY Change	-1.97%	5.68%
Gross Profit Margin	47.23%	48.13%
Selling, General & Admin	$890.0K	$918.0K
YoY Change	13.23%	2.91%
% of Gross Profit	85.0%	85.0%
Research & Development	$264.0K	$262.0K
YoY Change	10.92%	-2.24%
% of Gross Profit	25.21%	24.26%
Depreciation & Amortization	$23.00K	$24.00K
YoY Change	0.0%	0.0%
% of Gross Profit	2.2%	2.22%
Operating Expenses	$1.154M	$1.180M
YoY Change	12.7%	1.72%
Operating Profit	-$107.0K	-$100.0K
YoY Change	-343.18%	-27.54%
Interest Expense	$109.0K	$116.0K
YoY Change	15.96%	24.73%
% of Operating Profit
Other Income/Expense, Net	$109.0K	$116.0K
YoY Change	15.96%	24.73%
Pretax Income	$2.000K	$16.00K
YoY Change	-98.55%	-135.56%
Income Tax	$6.000K	$5.000K
% Of Pretax Income	300.0%	31.25%
Net Earnings	-$4.000K	$11.00K
YoY Change	-103.45%	-125.0%
Net Earnings / Revenue	-0.18%	0.49%
Basic Earnings Per Share	$0.00	$0.00
Diluted Earnings Per Share	$0.00	$0.00
COMMON SHARES
Basic Shares Outstanding	3.428M shares	3.428M shares
Diluted Shares Outstanding	3.428M shares	3.428M shares

Balance Sheet

Concept	2024 Q2	2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$9.944M	$10.13M
YoY Change	3.27%	5.91%
Cash & Equivalents	$9.888M	$10.07M
Short-Term Investments	$56.00K	$56.00K
Other Short-Term Assets	$177.0K	$218.0K
YoY Change	-20.98%	1.4%
Inventory	$1.865M	$1.811M
Prepaid Expenses
Receivables	$1.180M	$1.119M
Other Receivables	$41.00K	$0.00
Total Short-Term Assets	$13.21M	$13.28M
YoY Change	1.58%	2.68%
LONG-TERM ASSETS
Property, Plant & Equipment	$930.0K	$927.0K
YoY Change	0.11%	-2.63%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$330.0K	$336.0K
YoY Change	-4.07%	9.8%
Total Long-Term Assets	$1.260M	$1.263M
YoY Change	-1.02%	0.4%
TOTAL ASSETS
Total Short-Term Assets	$13.21M	$13.28M
Total Long-Term Assets	$1.260M	$1.263M
Total Assets	$14.47M	$14.54M
YoY Change	1.35%	2.48%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$199.0K	$189.0K
YoY Change	-44.1%	-47.06%
Accrued Expenses	$439.0K	$494.0K
YoY Change	1.86%	16.78%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$638.0K	$744.0K
YoY Change	-19.24%	-9.38%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$638.0K	$744.0K
Total Long-Term Liabilities	$0.00	$0.00
Total Liabilities	$638.0K	$744.0K
YoY Change	-19.24%	-9.38%
SHAREHOLDERS EQUITY
Retained Earnings	$11.19M	$11.19M
YoY Change	1.91%	3.04%
Common Stock	$2.639M	$2.601M
YoY Change	5.35%	3.83%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$13.83M	$13.80M
YoY Change
Total Liabilities & Shareholders Equity	$14.47M	$14.54M
YoY Change	1.35%	2.48%

Cashflow Statement

Concept	2024 Q2	2024 Q1
OPERATING ACTIVITIES
Net Income	-$4.000K	$11.00K
YoY Change	-103.45%	-125.0%
Depreciation, Depletion And Amortization	$23.00K	$24.00K
YoY Change	0.0%	0.0%
Cash From Operating Activities	-$158.0K	$202.0K
YoY Change	-1416.67%	-236.49%
INVESTING ACTIVITIES
Capital Expenditures	$26.00K	$0.00
YoY Change		-100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$26.00K	$0.00
YoY Change	-153.06%	-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000	$0.00
YoY Change	-100.0%	-100.0%
NET CHANGE
Cash From Operating Activities	-158.0K	$202.0K
Cash From Investing Activities	-26.00K	$0.00
Cash From Financing Activities	0.000	$0.00
Net Change In Cash	-184.0K	$202.0K
YoY Change	-406.67%	-109.59%
FREE CASH FLOW
Cash From Operating Activities	-$158.0K	$202.0K
Capital Expenditures	$26.00K	$0.00
Free Cash Flow	-$184.0K	$202.0K
YoY Change	-1633.33%	-235.57%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	11000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	48000	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10072000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1000	usd
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3428021	shares
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	14445000	usd
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	355000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-100000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3428021	shares
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	0	usd
CY2024Q1	dei	Entity Registrant Name EntityRegistrantName	ELECTRO SENSORS INC
CY2024Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000351789
CY2024Q1	dei	Amendment Flag AmendmentFlag	false
CY2024Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q1	dei	Entity File Number EntityFileNumber	000-09587
CY2024Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MN
CY2024Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	41-0943459
CY2024Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	6111 Blue Circle Drive
CY2024Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Minnetonka
CY2024Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	MN
CY2024Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	55343-9108
CY2024Q1	dei	City Area Code CityAreaCode	952
CY2024Q1	dei	Local Phone Number LocalPhoneNumber	930-0100
CY2024Q1	dei	Security12b Title Security12bTitle	Common stock, $0.10 par value
CY2024Q1	dei	Trading Symbol TradingSymbol	ELSE
CY2024Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2024Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024Q1	dei	Entity Shell Company EntityShellCompany	false
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	3428021	shares
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9870000	usd
CY2024Q1	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	56000	usd
CY2023Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	56000	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	11000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	11000	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1119000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1283000	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	1811000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	1751000	usd
CY2024Q1	us-gaap	Other Assets Current OtherAssetsCurrent	218000	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	179000	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	13276000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	13139000	usd
CY2024Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	336000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	927000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	951000	usd
CY2024Q1	us-gaap	Assets Assets	14539000	usd
CY2023Q4	us-gaap	Assets Assets	14445000	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	189000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	291000	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	494000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	323000	usd
CY2024Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	61000	usd
CY2023Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	76000	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	744000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	690000	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.1
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.1
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10000000	shares
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10000000	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3428021	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3428021	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3428021	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	342000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	342000	usd
CY2024Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	2259000	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	2230000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	11194000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	11183000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	13795000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	13755000	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	14539000	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	2244000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	2045000	usd
CY2024Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1164000	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1023000	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	1080000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	1022000	usd
CY2024Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	351000	usd
CY2023Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	370000	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	567000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	522000	usd
CY2024Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	262000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	268000	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	1180000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	1160000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-138000	usd
CY2024Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	116000	usd
CY2023Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	93000	usd
CY2024Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	116000	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	93000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-45000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-44000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	0	usd
CY2023Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-4000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-4000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	11000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-48000	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3428021	shares
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3428021	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3428021	shares
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	13755000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	29000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	11000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	13414000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-4000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-44000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	13366000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	11000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-44000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	24000	usd
CY2024Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	19000	usd
CY2023Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-50000	usd
CY2024Q1	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	29000	usd
CY2023Q1	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	0	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-164000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	211000	usd
CY2024Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	60000	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	34000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	39000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	1000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-102000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	83000	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	171000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	73000	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-15000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	202000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-112000	usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	0	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1000	usd
CY2024Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	0	usd
CY2023Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	2000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	0	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	202000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-115000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9870000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9626000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10072000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9511000	usd
CY2024Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
CY2023Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	11000	usd
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<p style="margin: 0pt; line-height: 1.2;"><span style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; line-height: inherit;">Use of Estimates</span></p> <p style="margin: 0pt; line-height: 1.2;"><span style="font-family: 'Times New Roman'; font-size: 8pt; line-height: inherit;"> </span></p> <p style="margin: 0pt; line-height: 1.2;"><span style="font-family: 'Times New Roman'; font-size: 10pt; margin: 0pt; line-height: inherit;"><span style="font-family: 'Times New Roman'; font-size: 10pt; line-height: inherit;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates. Current significant estimates, including the underlying assumptions, consist of economic lives of long-lived assets, realizability of trade receivables, and valuation of deferred tax assets/liabilities, inventory, investments, and stock compensation expense. It is at least reasonably possible that these estimates may change in the near term</span>. </span></p>
CY2024Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="margin: 0in 0in 0.0001pt; font-size: 10pt; font-family: 'Times New Roman', serif; text-align: left; line-height: 1.2;"><span style="font-weight: bold; line-height: inherit;">Reclassification of Prior Year Presentation</span></p> <p style="margin: 0in 0in 0.0001pt; font-size: 10pt; font-family: 'Times New Roman', serif; text-align: left; line-height: 1.2;"><br/></p> <p style="margin: 0in 0in 0.0001pt; font-size: 10pt; font-family: 'Times New Roman', serif; text-align: left; line-height: 1.2;">All Treasury Bills have been reclassified to cash equivalents for consistency with the current year presentation. The reclassification had no effect on the reported results of operations. The Balance Sheet and Statement of Cash Flows have been adjusted to reflect this reclassification.</p>
CY2024Q1	else	Number Of Private Companies Which Entity Has Investments In Common Equity Securities NumberOfPrivateCompaniesWhichEntityHasInvestmentsInCommonEquitySecurities	2
CY2024Q1	else	Available For Sale Marketable Securities Amortized Cost AvailableForSaleMarketableSecuritiesAmortizedCost	54000	usd
CY2024Q1	else	Available For Sale Marketable Securities Accumulated Gross Unrealized Gain AvailableForSaleMarketableSecuritiesAccumulatedGrossUnrealizedGain	2000	usd
CY2024Q1	else	Available For Sale Marketable Securities Accumulated Gross Unrealized Loss AvailableForSaleMarketableSecuritiesAccumulatedGrossUnrealizedLoss	0	usd
CY2024Q1	us-gaap	Marketable Securities MarketableSecurities	56000	usd
CY2023Q4	else	Available For Sale Marketable Securities Amortized Cost AvailableForSaleMarketableSecuritiesAmortizedCost	54000	usd
CY2023Q4	else	Available For Sale Marketable Securities Accumulated Gross Unrealized Gain AvailableForSaleMarketableSecuritiesAccumulatedGrossUnrealizedGain	2000	usd
CY2023Q4	else	Available For Sale Marketable Securities Accumulated Gross Unrealized Loss AvailableForSaleMarketableSecuritiesAccumulatedGrossUnrealizedLoss	0	usd
CY2023Q4	us-gaap	Marketable Securities MarketableSecurities	56000	usd
CY2023Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	56000	usd
CY2022Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	56000	usd
CY2024Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease	0	usd
CY2024Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	56000	usd
CY2023Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	56000	usd
CY2024Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	1135000	usd
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	1172000	usd
CY2024Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	324000	usd
CY2023Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	301000	usd
CY2024Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	362000	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	288000	usd
CY2024Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	10000	usd
CY2023Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	10000	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	1811000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	1751000	usd
CY2024Q1	us-gaap	Loss Contingency Disclosures LossContingencyDisclosures	<div style="font-family: 'times new roman', times; font-size: 10pt;"> <p style="margin: 0px; text-indent: 0px; line-height: 1.2;"><span style="font-weight: bold; font-size: 10pt; line-height: inherit;">Note 6. Contingencies</span><br/></p> </div> <p style="line-height: 1.2; margin: 0in; font-size: 10pt; font-family: "Times New Roman", serif;"><span style="font-family: 'Times New Roman'; font-size: 10pt; line-height: inherit;"> </span></p> <div style="font-family: "Times New Roman"; font-size: 10pt; line-height: 1.2;">The Company at times becomes subject to claims against it in the ordinary course of business. There are currently <span>no</span> pending or threatened claims against the Company that it believes will have a material adverse effect on its results of operations or liquidity.</div>

Files In Submission

Name	View Source	Status
0000897101-24-000170-index-headers.html	Edgar Link	pending
0000897101-24-000170-index.html	Edgar Link	pending
0000897101-24-000170.txt	Edgar Link	pending
0000897101-24-000170-xbrl.zip	Edgar Link	pending
else-20240331.htm	Edgar Link	pending
else-20240331.xsd	Edgar Link	pending
ex311_1.htm	Edgar Link	pending
ex321_2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
else-20240331_def.xml	Edgar Link	unprocessable
else-20240331_lab.xml	Edgar Link	unprocessable
else-20240331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
else-20240331_htm.xml	Edgar Link	completed
else-20240331_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ELSE
ELECTRO SENSORS INC Stock $else

2024 Q2 Form 10-Q Financial Statement

#000089710124000170 Filed on May 10, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ELSE ELECTRO SENSORS INC Stock $else

2024 Q2 Form 10-Q Financial Statement

#000089710124000170 Filed on May 10, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ELSE
ELECTRO SENSORS INC Stock $else